We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Download Mobile App




International Societies Suggest Key Considerations for AI Radiology Tools

By MedImaging International staff writers
Posted on 02 Feb 2024
Print article
Image: The RSNA has published a joint statement on the use of AI tools in radiology (Photo courtesy of 123RF)
Image: The RSNA has published a joint statement on the use of AI tools in radiology (Photo courtesy of 123RF)

Artificial intelligence (AI) holds the potential to significantly disrupt the field of radiology, presenting both opportunities and challenges. Its integration could transform healthcare by enhancing the diagnosis, quantification, and management of various medical conditions. However, as AI tools in radiology become more accessible and sophisticated, there's a growing need to critically assess their utility and distinguish between safe and effective products versus those that are potentially harmful or ineffective.

Now, RSNA (Oak Brook, IL, USA), along with four international radiology societies, has issued a joint statement on the development and application of AI tools in radiology. Published in RSNA's journal, Radiology: Artificial Intelligence, the paper titled "Developing, Purchasing, Implementing and Monitoring AI Tools in Radiology: Practical Considerations. A Multi-Society Statement from the ACR, CAR, ESR, RANZCR, and RSNA" highlights potential practical and ethical issues related to integrating AI into radiology practice. It outlines key concerns for developers, regulators, and purchasers of AI tools before their clinical implementation. The statement also proposes methods for monitoring these tools for stability and safety in clinical settings and evaluating their readiness for potential autonomous operation.

The authors discuss various critical aspects of incorporating AI into the medical imaging workflow. They emphasize the need for heightened monitoring of AI's utility and safety once integrated into clinical practice. The statement underscores the importance of collaboration among developers, clinicians, and regulators to navigate ethical issues and oversee AI performance. AI has the potential to significantly benefit patient well-being, but this requires thorough scrutiny at every stage, from development to integration into healthcare systems. This multi-society statement serves as a guideline for developers, purchasers, and users of AI in radiology, ensuring clarity and comprehension of practical challenges throughout all phases of AI development, from its inception to sustained healthcare integration, with patient and societal safety and well-being as the foremost priorities.

"AI tools are an essential part of radiology's future," said RSNA President Curtis P. Langlotz, M.D., Ph.D. "RSNA is committed to supporting the responsible use of AI in medical imaging through all three pillars of its mission: education, research, and technological innovation."

Related Links:
RSNA

Silver Member
X-Ray QA Meter
T3 AD Pro
New
Mammo 3D Performance Kits
Mammo 3D Performance Kits
Ultrasound Scanner
TBP-5533
Digital X-Ray Detector Panel
Acuity G4

Print article

Channels

Ultrasound

view channel
Image: The novel method of fighting cancer can stimulate critical cytokine secretion in T cells

Ultrasound-Directed Microbubbles Boost Immune Response Against Tumors

A significant challenge in cancer treatment is the tumor's ability to suppress the immune system, particularly by deactivating T cells that enter the tumor. Once inside, the tumor can inhibit T cells from... Read more

Nuclear Medicine

view channel
Image: PSMA-PET/CT images of an 85-year-old patient with hormone-sensitive prostate cancer (Photo courtesy of Dr. Adrien Holzgreve)

Advanced Imaging Reveals Hidden Metastases in High-Risk Prostate Cancer Patients

Prostate-specific membrane antigen–positron emission tomography (PSMA-PET) imaging has become an essential tool in transforming the way prostate cancer is staged. Using small amounts of radioactive “tracers,”... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.